Events
FDLI 2021 Advertising and Promotion for Medical Products Conference
October 15, 2021

On October 15th, Axinn partner Chad Landmon will moderate a panel entitled, "Advertising and Promotion of Reference and Biosimilar Products—Where are We Now?" at the virtual FDLI 2021 Advertising and Promotion for Medical Products Conference.

This session will examine how FDA guidance has impacted the industry’s decision-making around entering the reference and biosimilar product markets. The panel will also gauge how interchangeable-specific issues are playing out and whether additional solutions may be needed.

Click here for more information, including how to register.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.